Show Cart

News Channels

19 Jan 2019 Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies
19 Jan 2019 AVROBIO, Inc. Announces Acceptance of Investigational New Drug (IND) Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis
19 Jan 2019 TYME’s Novel Metabolic-Based Cancer Therapy, SM-88, Improves Survival in Phase II Study of Patients with Advanced Pancreatic Cancer
19 Jan 2019 Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression
19 Jan 2019 Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors, Opening Potential for CAR-T and Other Cellular Medicines in New Settings
19 Jan 2019 AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer
18 Jan 2019 Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®
18 Jan 2019 Free report: TOP 25 Pharma Groups analyzed for sales, R&D costs, operating and net income by business segments
18 Jan 2019 Zymeworks Reports Second Investigational New Drug (IND)-Submission Milestone Achieved in Lilly Collaboration
18 Jan 2019 Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
18 Jan 2019 AgeneBio Announces First Patient Enrollment in the Phase 3 Clinical Trial to Evaluate AGB101 to Treat Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease
18 Jan 2019 OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy
18 Jan 2019 Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application
17 Jan 2019 Janssen announces European Commission approval of ERLEADA® (apalutamide) for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
17 Jan 2019 Ipsen Presents the Results of the First in-Human Study of a Recombinant Fast-Acting Neurotoxin (rBoNT-E) at TOXINS 2019
17 Jan 2019 United Neuroscience Announces Positive Top-Line Results from Phase 2a Clinical Study of UB-311 Vaccine in Patients with Alzheimer's Disease
17 Jan 2019 AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial
17 Jan 2019 Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Gastric Cancer
17 Jan 2019 Vaccinex, Inc. Announces Completion of Enrollment for Its “SIGNAL” Huntington’s Disease Trial
17 Jan 2019 Aeterna Zentaris Receives European Marketing Clearance for Macimorelin

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top